Responses
BCS Abstracts 2013
073 ATRIAL FIBRILLATION ABLATION UNDER THERAPEUTIC WARFARIN IS SAFE WITH IMPROVED PATIENTS' EXPERIENCE AND POTENTIALLY COST-SAVING COMPARED TO BRIDGING LOW MOLECULAR WEIGHT HEPARIN
Compose a Response to This Article
Other responses
No responses have been published for this article.